1,1,2,2-Tetrakis(4-(pyridin-3-yl)phenyl)ethene, 98%, 250mg

(S)-N-Glycidylphthalimide, 95.0%, 10g

2-[(5-Bromo-2-pyridinyl)oxy]acetic acid, 25g

3-((Tert-butoxycarbonyl)amino)phthalic acid, 97%, 250mg

Methyl 3-amino-4-(trifluoromethoxy)benzoate, 97%, 5g

5-BROMO-3-HYDROXY-2-METHYLBENZOIC ACID, 95.0%, 1g

Dimroth condenser, 400 mm, 29/32, 1 Piece

ETHYL 7-METHOXY-1H-INDOLE-2-CARBOXYLATE, 97.0%, 100mg

4-BROMO-2,7-DIMETHYL-2H-INDAZOLE, 95.0%, 250mg

(4-Chloro-phenyl)-morpholin-4-yl-acetic acid, 95.0%, 50mg

(S)-3-(1-(tert-Butoxycarbonyl)-1H-imidazol-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 1g

Linsitinib, 100mg

(2S,4S)-1-(2-chloroacetyl)-4-fluoropyrrolidine-2-carbonitrile, 95+%, 1g